EcoDrugPlus

Ribosomal Protein L14

Ensembl ID : ENSSVLG00005021436
Gene Symbol: RPL14
1 Cross references
223 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSSVLG00005023393
Gene Symbol: RPL15
1 Cross references
110 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSSVLG00005025287
Gene Symbol: RPL18A
1 Cross references
164 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSSVLG00005014616
Gene Symbol: RPL19
1 Cross references
241 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSSVLG00005000734
Gene Symbol: RPL22
1 Cross references
89 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSSVLG00005015395
Gene Symbol: RPL23
1 Cross references
227 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSSVLG00005019027
Gene Symbol: RPL24
1 Cross references
221 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSSVLG00005018682
Gene Symbol: RPL27A
1 Cross references
218 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSSVLG00005023771
Gene Symbol: RPL28
1 Cross references
206 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSSVLG00005015871
Gene Symbol: RPL3
1 Cross references
279 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSSVLG00005014028
Gene Symbol: RPL31
1 Cross references
213 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSSVLG00005026009
Gene Symbol: RPL34
1 Cross references
170 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).